This page shows the latest Gyroscope news and features for those working in and with pharma, biotech and healthcare.
Swiss pharma Novartis is set to buy UK-based gene therapy company, Gyroscope Therapeutics, for an upfront payment of $800m and another $700m in milestone payments. ... Gyroscope is a clinical-stage gene therapy company working on eye diseases that cause
This was an apparent reference to Gyroscope, the company based in the Stevenage biotech cluster near London, which is testing its gene therapy for advanced dry Age-related Macular Degeneration (AMD).
This will help frees up its portfolio for new investments. Since 31 March 2019, Syncona has invested £64.1min to its portfolio companies, including gene therapy companies Freeline and Gyroscope and
Quell is the tenth life science company founded by Syncona, with other UK-based cell and gene therapy companies on its roster including Gyroscope and Freeline.
News mirrors Ocugen and Histogenics merger. UK-based Gyroscope is to merge with Orbit Biomedical to further develop its gene therapy platform for eye diseases. ... will hopefully cure eye diseases that today leave people blind,” said Gyroscope’s
These include Freeline, which last year raised £88m to accelerate haemophilia gene therapy, and Gyroscope, which earlier this month dosed its first patient with its gene therapy for dry AMD, and
More from news
Approximately 2 fully matching, plus 10 partially matching documents found.
Women trailblazers helping to shape the future of healthcare (Part 1)
One notable exception to that is Soraya Bekkali, president, head of R&D at Gyroscope, a UK firm developing gene therapies for eye diseases. ... Between 2017 and March 2019 Soraya served as CEO and CMO of Gyroscope and led the company successfully to
Exact details remain vague, but Apple said in a statement that researchers would be able to ask for access to the accelerometer, microphone, gyroscope and GPS sensors in the iPhone “to
More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.
Dr Soraya Bekkali joins from biotech firm Lysogene. Ophthalmology group Gyroscope Therapeutics has appointed Dr Soraya Bekkali as its chief executive officer and director of its board. ... Gyroscope has a unique translational approach to tackling complex
She joins from Gyroscope Therapeutics to take up CEO role. London, UK-based gene therapy-focused biopharmaceutical company Freeline Therapeutics has appointed Anne Prener as its new chief executive officer. ... Prior to Gyroscope, Frener served as vice
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
The glasses connect wirelessly with compatible smartphones and are equipped with an accelerometer, gyroscope, electronic compass, brightness sensor, microphone and camera.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...